ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 64

The Effect of Adenosine A2A Receptor Stimulation on Mitochondrial Metabolism in the Pathogenesis and Treatment of Osteoarthritis

Cristina Castro1, Carmen Corciulo2 and Bruce Cronstein3, 1Medicine, NYU School of Medicine, New York, NY, 2Department of Medicine, Division of Rheumatology, NYU School of Medicine, New York, NY, 3Rheumatology, New York University School of Medicine, Division of Rheumatology, New York, NY

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Adenosine receptors, mitochondria and osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Biology and Pathology of Bone and Joint Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Osteoarthritis (OA) is the most common form of arthritis, affecting nearly 10% of the US population. There is no therapy to prevent the progression of or reverse OA pathology. Endogenous adenosine 2A receptor (A2AR) stimulation is crucial for chondrocyte viability and cartilage homeostasis as its downstream signaling mediates inflammation. In recent preliminary studies we have found that mice lacking the A2AR or ecto-5’nucleotidase (CD73, an ectoenzyme critical for extracellular adenosine production) develop spontaneous OA. These findings suggest that diminished extracellular adenosine levels promote the development of OA. Since human OA chondrocytes have been found to have diminished mitochondrial content, we propose to test the hypothesis that OA pathogenesis deregulates A2AR signaling at least in part by affecting the cell’s capacity for ATP production via reduced number or functionality of mitochondria.

Methods: A human chondrocyte cell line, TC28a2, was used to determine the effects of IL1B-induced inflammation and A2AR stimulation in vitro. Cells were treated with IL1B (5ng/mL) and with the A2AR-specific agonist, CGS21680 (CGS; 1uM). Mitochondrial content was measured by mtDNA to nDNA ratios and MitoTracker mean cellular intensity. Mitochondrial health and functionality was assessed by mean pixel intensity (MPI) of a fluorescent probe for monitoring mitochondrial membrane potential, TMRM, and by measuring oxygen consumption rates (OCR) on Seahorse Mito Stress Kit Assays. The role of A2AR ligation on mitochondrial health was also studied by histology for 8hydroxyguanosine (8OH-G) residues as a marker for reactive oxygen species (ROS) in A2ARKO mice and Sprague Dawly rats that underwent ACL rupture (post-traumatic OA model) and subsequently received CGS-filled liposomal injections.

Results: A2AR agonism increases mitochondrial content in vitro. IL1B incubation for 3 hours followed by A2AR ligation increases mitochondrial membrane potential (2867±165.5 MPI) compared to control (1582±183.9 MPI), IL1B alone (1483±120.6 MPI) and CGS alone (1788±137.8 MPI) as measured by TMRM staining (p≤0.0001). IL1B incubation for 4 hours with a last hour of A2AR stimulation increases basal oxygen consumption rate and maximal respiratory rate. IL1B+CGS treated cells had significantly increased ATP production (113.04±13.44 of OCR) than the control (83.86±11.89 of OCR), IL1B (81.00±12.80 of OCR) and CGS (76.04± 23.52 of OCR) treated cells as measured by one-way ANOVA (p values =**0.0088, *0.0128, and *0.0259 respectively). A2ARKO mice exhibit increased 8OG-G staining in histology as early as 8 weeks. A2AR stimulation after ACL rupture in rats, results in preserved cartilage volumes, improved OARSI scores (p<0.001) and reduced ROS as seen by reduced 8OH-G staining in histology.

Conclusion: A2AR ligation improves mitochondrial functionality during inflammation and OA progression. Increased mitochondrial function is not seen when the chondrocytes are treated with IL1B or CGS alone; perhaps suggesting that A2AR stimulation is necessary to maintain homeostasis when cells are already under physiological or pathological stress.


Disclosure: C. Castro, None; C. Corciulo, None; B. Cronstein, NIH grant, 2,Athritis foundation grant, 2,AstraZeneca, 2,Celgene, 2,Eli Lilly & Co., 5,AstraZeneca, 5,Canfite Biopharma, 1.

To cite this abstract in AMA style:

Castro C, Corciulo C, Cronstein B. The Effect of Adenosine A2A Receptor Stimulation on Mitochondrial Metabolism in the Pathogenesis and Treatment of Osteoarthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/the-effect-of-adenosine-a2a-receptor-stimulation-on-mitochondrial-metabolism-in-the-pathogenesis-and-treatment-of-osteoarthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-effect-of-adenosine-a2a-receptor-stimulation-on-mitochondrial-metabolism-in-the-pathogenesis-and-treatment-of-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology